The difference in prognostic value between high sensitive cardiac troponin T and I for long-term major adverse cardiovascular events in hemodialysis patients

The difference in prognostic value between high sensitive cardiac troponin T and I for long term major adverse cardiovascular events in hemodialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20220322008

Enrollment

194

Registered

2022-03-22

Start date

2021-05-13

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic hemodialysis patients cardiac troponin cardiovascular outcome end-stage renal disease hemodialysis prognostic value

Interventions

ESRD patients, aged more than 18 years, who had undergone regular hemodialysis for more than 3 months at the hemodialysis unit at Chiang Mai University hospital

Screening

Chronic hemodialysis patients

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Age more than 18 years ESRD patients with regular hemodialysis (two to three times a week) more than 90 days.

Exclusion criteria

Exclusion criteria: Recent diagnosis acute myocardial infarction, heart failure and pulmonary embolism within previous 6 months Major surgery and trauma within previous 4 weeks Pregnancy Undergone coronary and/or valvular intervention within previous 6 months

Design outcomes

Primary

Measure	Time frame
Prognostic value of high sensitivity cardiac troponin T and I for all cause mortality 1 year Mortality rate	—

Secondary

Measure	Time frame
Prognostic value of high sensitivity cardiac troponin T and I for major adverse cardiovascular events 1 year Number of event	—

Countries

Thailand

Contacts

Public ContactKannika Ratnachina

Faculty of medicine

Apple_1611@hotmail.com0653949544

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026